Blue Flower

19 January 2021

  • Naltrexone use decreases the risk of hospitalization in persons with alcohol use disorder
    Naltrexone, used either alone or together with disulfiram or acamprosate, is associated with a decreased risk of hospitalization due to alcohol use disorder (AUD) when compared with non-use of AUD drugs, a new register-based study shows. The same associations were noticed for hospitalization due to any cause. Disulfiram use and polytherapy with two or more drugs indicated for AUD was associated with a decreased risk of hospitalization due to alcohol-related somatic causes. None of the studied medications were associated with mortality or work disability (sickness absence or disability pension). The study was published in Addiction.
  • A quarter of adults reported drinking more during first lockdown
    A quarter of people in the UK reported drinking more than usual during the first lockdown, particularly those who were younger, female and suffering from anxiety, finds a study by UCL researchers.
  • Principles of care established for young adults with substance use disorders
    A national group of pediatric addiction medicine experts have released newly-established principles of care for young adults with substance use disorder. Led by the Grayken Center for Addiction at Boston Medical Center, the collection of peer-reviewed papers was developed to guide providers on how to treat young adults with substance use disorder given their age-specific needs, as well as elevate national discussions on addressing these challenges more systematically.
  • A good time to quit: Smoking and vaping amid COVID-19
    As COVID-19 infections continue to rise and cold and flu season take hold, physicians are adamantly advising patients to do all they can to remain healthy—including not smoking or vaping.
  • Research offers roadmap to address sex differences in opioid epidemic
    The opioid epidemic continues in this country in the midst of the current COVID-19 pandemic in the United States.